Aldo P. Maggioni

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Among patients with a recent myocardial infarction, colchicine at a dose of 0.5 mg daily led to a significantly lower risk of ischemic cardiovascular events than placebo. (Funde...

Initial Invasive or Conservative Strategy for Stable Coronary Disease

Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative...

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

Sacubitril-valsartan did not result in a significantly lower rate of total hospitalizations for heart failure and death from cardiovascular causes among patients with heart fail...

Empagliflozin in Patients with Chronic Kidney Disease

Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease o...